Trinity Biotech's total assets for Q3 2025 were $103.71M, an increase of 4.10% from the previous quarter. TRIB total liabilities were $158.43M for the fiscal quarter, a 6.21% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.